58.14
Biomarin Pharmaceutical Inc 주식(BMRN)의 최신 뉴스
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo.co
Should I hold or sell BioMarin Pharmaceutical Inc. stock in 2025Achieve rapid wealth accumulation through smart investing - jammulinksnews.com
Leerink Partners Maintains a Buy on BioMarin Pharmaceutical (BMRN), Retains a $105 PT - Insider Monkey
Why is BioMarin Pharmaceutical Inc. stock attracting strong analyst attentionBuild wealth with reliable stock picks - jammulinksnews.com
What is BioMarin Pharmaceutical Inc. company’s growth strategyTrack top-performing stocks in real-time - jammulinksnews.com
What are analysts’ price targets for BioMarin Pharmaceutical Inc. in the next 12 monthsTremendous return rates - jammulinksnews.com
What catalysts could drive BioMarin Pharmaceutical Inc. stock higher in 2025Unlock exclusive trading strategies for gains - jammulinksnews.com
When is BioMarin Pharmaceutical Inc. stock expected to show significant growthConsistently outstanding ROI - jammulinksnews.com
What makes BioMarin Pharmaceutical Inc. stock price move sharplyCapitalize on high-yield stocks early - jammulinksnews.com
10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey
Is BioMarin Pharmaceutical Inc. a good long term investmentStrongest growth potential - PrintWeekIndia
What analysts say about BioMarin Pharmaceutical Inc. stockOutstanding growth strategies - PrintWeekIndia
Published on: 2025-07-25 23:58:58 - PrintWeekIndia
What risks could impact BioMarin Pharmaceutical Inc. stock performanceExceptional ROI - jammulinksnews.com
BioMarin’s BMN 349: A Promising Step in Genetic Lung Condition Treatment - TipRanks
Will BioMarin Pharmaceutical Inc. stock benefit from AI tech trendsFree Consultation - jammulinksnews.com
BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET - Eastern Progress
BioMarin: Less Likely M&A Target As New Rival For Best-Selling Drug Emerges (Rating Downgrade) - Seeking Alpha
BioMarin Pharmaceutical Inc. Stock Analysis and ForecastOutstanding growth strategies - Autocar Professional
What drives BioMarin Pharmaceutical Inc. stock priceAccelerated earnings growth - Autocar Professional
Investors Still Waiting For A Pull Back In BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - simplywall.st
BioMarin Bets On Growth, But Competition Keeps Pressure On - Finimize
자본화:
|
볼륨(24시간):